d) at AGC Biologics

Heidelberg, Baden-Württemberg, Germany

Apply Now

Not SpecifiedCompensation

InternshipExperience Level

Full TimeJob Type

UnknownVisa

Biotechnology, PharmaceuticalsIndustries

Requirements

Bachelor student (m/f/d) with background in electrical engineering, automation and control or related fields
Strong programming / robotics focus

Responsibilities

Design and plan the Tangential Flow Filtration (TFF) system (Stage 1: Design and Planning)
Perform physical assembly and wiring of the system (Stage 2: Physical Assembly and Wiring)
Develop and program the software for the system (Stage 3: Software Development and Programming)
Commission and test the system (Stage 4: Commissioning and Testing)
Document the project and write the bachelor's thesis (Stage 5: Documentation and Thesis Writing)
Lead the project lifecycle from concept to fully functional automated laboratory equipment

Skills

Tangential Flow Filtration

TFF

Automation

Control Technology

Programming

Mechatronics

Software Development

Robotics

Electrical Engineering

Process Development

Buffer Exchange

PEGylation

AGC Biologics

Contract development and manufacturing for biopharmaceuticals

About AGC Biologics

AGC Biologics specializes in the development and manufacturing of therapeutic proteins, plasmid DNA, viral vectors, and genetically engineered cells for the biopharmaceutical industry. The company provides end-to-end solutions, assisting clients from the initial development stages to full-scale production. Their services are particularly focused on fast-tracking projects for orphan drugs and rare diseases, which often require quicker timelines. AGC Biologics operates a network of advanced facilities across the U.S., Europe, and Asia, all adhering to strict quality regulations known as current Good Manufacturing Practices (cGMP). What sets AGC Biologics apart from competitors is its commitment to continuous innovation and its recent expansion to enhance capabilities in cell and gene therapy. The company's goal is to support biopharmaceutical companies in bringing new treatments to market efficiently and effectively.

Bothell, WashingtonHeadquarters

2001Year Founded

$613MTotal Funding

ACQUISITIONCompany Stage

Biotechnology, HealthcareIndustries

1,001-5,000Employees

Risks

Restructuring and layoffs in Colorado indicate potential financial instability.

Leadership changes may disrupt ongoing projects and affect client trust.

Significant investment in Japan could strain financial resources and divert focus.

Differentiation

AGC Biologics specializes in therapeutic proteins, plasmid DNA, and viral vectors.

The company offers fast-track project capabilities for orphan drugs and rare diseases.

AGC Biologics operates globally with facilities in the U.S., Europe, and Asia.

Upsides

Increased demand for plasmid DNA boosts AGC's gene therapy and vaccine services.

Partnership with BioConnection enhances biodrug development capabilities, attracting more clients.

Expansion in Yokohama aligns with growing mRNA and cell therapy demand.

Land your dream remote job 3x faster with AI

Try Jobo Free